Deutsche Bank Ag\ Akari Therapeutics PLC Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.06 - $2.16 $1,088 - $2,218	-1,027 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.69 - $2.16 $1,735 - $2,218	1,027 New	1,027 $1,000
Q3 2019 Nov 14, 2019	SELL	$1.69 - $2.92 $223,080 - $385,440	-132,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.89 - $4.01 $213,570 - $453,130	113,000 Added 594.74%	132,000 $266,000
Q1 2019 May 15, 2019	BUY	$1.66 - $5.9 $31,540 - $112,100	19,000 New	19,000 $68,000
Q1 2018 May 15, 2018	SELL	$1.77 - $4.39 $5,664 - $14,047	-3,200 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$4.08 - $7.4 $8,568 - $15,540	-2,100 Reduced 39.62%	3,200 $13,000
Q3 2017 Nov 14, 2017	BUY	$3.42 - $8.74 $18,126 - $46,322	5,300	5,300 $32,000

Ticker AKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,349,200
Market Cap $145M
Description
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.